siRNA therapy lowers triglycerides in individuals along with uncommon problem
.INVESTIGATION HIGHLIGHT.19 September 2024.
Plozasiran decreased triglyceride degrees through 80% as well as reduced the threat of pancreatitis in clients along with persistent chylomicronemia, along with or without a genetic prognosis.